|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Teva_Pharmaceutical_Industries
|
|
gptkbp:acquisitionYear
|
2016
|
|
gptkbp:countryOfOrigin
|
gptkb:United_States
|
|
gptkbp:formerName
|
gptkb:Watson_Pharmaceuticals
|
|
gptkbp:founded
|
1984
|
|
gptkbp:headquartersLocation
|
gptkb:Parsippany,_New_Jersey,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Actavis Generics
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:keyPerson
|
gptkb:Paul_Bisaro
|
|
gptkbp:mergedInto
|
gptkb:Teva_Pharmaceutical_Industries
|
|
gptkbp:notableAcquisition
|
gptkb:Allergan,_Inc.
gptkb:Durata_Therapeutics
gptkb:Warner_Chilcott
gptkb:Forest_Laboratories
|
|
gptkbp:numberOfEmployees
|
over 20,000 (before acquisition)
|
|
gptkbp:operatingStatus
|
acquired
|
|
gptkbp:parentCompany
|
gptkb:Teva_Pharmaceutical_Industries
|
|
gptkbp:products
|
generic drugs
|
|
gptkbp:tradedOn
|
gptkb:NYSE:_ACT
|
|
gptkbp:website
|
www.actavis.com
|
|
gptkbp:bfsParent
|
gptkb:Teva_Pharmaceutical_Industries
|
|
gptkbp:bfsLayer
|
5
|